January 8, 2018 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

Roche and GE enter partnership to develop integrated digital diagnostics platform to improve oncology and critical care treatment

Basel, 08 January 2018 Roche and GE enter partnership to develop integrated digital diagnostics platform to improve oncology and critical care treatment Companies aim to develop jointly-branded clinical decision support software for faster, more accurate, more confident decision-making, enabling earlier diagnosis and individualised treatment Partnership will apply advanced analytics to in-vivo data from GE’s medical... Read more

December 22, 2017 Licensing, IP, and Legal

Cellular Dynamics International Sends Human iPSC-Derived Cardiomyocytes To International Space Station On NASA Resupply Mission

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Astrocytes iCell Cardiac Progenitor Cells iCell Cardiomyocytes iCell Cardiomyocytes2 iCell DopaNeurons iCell Endothelial Cells iCell GABANeurons iCell GlutaNeurons iCell Hematopoietic Progenitor Cells iCell Hepatoblasts iCell Hepatocytes... Read more

December 20, 2017 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership

Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership WALTHAM, Mass., Dec. 20, 2017 /PRNewswire/ — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T)... Read more

December 15, 2017 Licensing, IP, and Legal

QIAGEN and Oxford Immunotec settle patent infringement lawsuit

Germantown, Maryland, and Hilden, Germany, December 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) and Oxford Immunotec Ltd. (NASDAQ: OXFD) announced today that they have reached a settlement in the lawsuit in the U.S. District Court for the District of Massachusetts in Boston (15-cv-13124-NMG) alleging patent infringement in relation to QIAGEN’s QuantiFERON®-TB... Read more

December 15, 2017 Licensing, IP, and Legal

QIAGEN and Oxford Immunotec settle patent infringement lawsuit

Agreement includes payment of $27.5 million to Oxford, royalty-free license to QIAGEN and dismissal of all pending litigation Germantown, Maryland, and Hilden, Germany, December 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) and Oxford Immunotec Ltd. (NASDAQ: OXFD) announced today that they have reached a settlement in the lawsuit in the U.S. District... Read more

December 13, 2017 Licensing, IP, and Legal M&A, Partnerships

Bruker and The Metropolitan Museum of Art Announce Partnership in the Field of Cultural Heritage Science

NEW YORK and BILLERICA, Mass., Dec. 13, 2017 /PRNewswire/ — The Metropolitan Museum of Art (The Met) and Bruker Corporation are pleased to announce a 10-year partnership to advance novel analytical technologies and methods in the field of cultural heritage science even further.  This partnership builds upon and expands a long history of collaboration that has... Read more

December 11, 2017 Environ, Ag./Food & Bev Licensing, IP, and Legal PR/Corporate

Illumina Names Aimee Hoyt Chief People Officer, Bringing 20+ Years of Senior Human Resources Leadership from Global Technology Companies

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced Aimee Hoyt, an accomplished and strategic talent leader, will head its human resources team. Ms. Hoyt will join as Senior Vice President and Chief People Officer (CPO), starting January 8, 2018, and will be responsible for leading all aspects of the company’s HR strategies, reporting to the CEO. “After... Read more

December 11, 2017 Licensing, IP, and Legal M&A, Partnerships

BD Establishes Product Security Partnership Program to Enhance Cybersecurity of Medical Technology

FRANKLIN LAKES, N.J., Dec. 11, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has established a Product Security Partnership Program that emphasizes collaboration across the health care industry to enhance cybersecurity of medical technology and devices. The new program has three primary components: Participation with... Read more

December 8, 2017 Lab Top-10 Licensing, IP, and Legal

Shimadzu Establishes Shimadzu Aerotech Manufacturing, Inc., a Commercial Aircraft Equipment Manufacturing Subsidiary

Shimadzu Corporation has established Shimadzu Aerotech Manufacturing, Inc., a subsidiary specializing in the manufacture of equipment for commercial aircraft, which includes strategic products in our aircraft equipment business. The company aims to raise production efficiency by specializing in the manufacture of commercial aircraft equipment positioned as strategic products to increase competitiveness and expand business performance.... Read more